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Aging is associated with modifications of the immune system, defined as immunosenescence.
This could contribute to a reduced prevalence of allergic disease in the elderly population.
In this regard, atopy has rarely been considered in the clinical assessment of the geriatric
respiratory patient. This article is a review of the available literature assessing the impact
of age on atopy. In the majority of papers, we found a lower prevalence of atopy in the most
advanced ages, both in healthy subjects and in individuals affected by allergic respiratory
diseases. Unfortunately, no large, longitudinal studies performed in the general population
have been conducted to further explore this observation. Although available data seem to
favor the decline of allergen sensitization with age, the prevalence of allergic sensitizations
in the elderly population with respiratory symptoms is substantial enough to warrant evalua-
tion of the atopic condition. From a clinical perspective, allergic reactions in older adults
can have the same or even worse manifestations compared to young people. For this reasons,
the evaluation of the atopic condition also in the geriatric patient is recommended. Thus, the
role of atopy as it pertains to the diagnosis, therapy (adoption of preventive measure such as
removal of environmental allergen or immunotherapy), and prognosis (influence on morbidity
and mortality) of chronic respiratory illnesses in the elderly is addressed.
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Over the past several decades, the elderly population has
steadily increased because of longer average lifetime. Aging
is characterized by a progressive decline of the function of
various systems and organs. As a result, the mechanisms of
chronic diseases are often influenced by pathophysiological
consequences of age-related changes. Aging is associated
with modifications of the immune system, defined as
immunosenescence.1e7 The size of the hematopoietic
compartment of bone marrow decreases with increasing age
and is replaced by fatty adipose tissue, implying that the
composition of bonemarrow stroma and its ability to nurture
hematopoietic precursors is substantially compromised with
aging. However, the hematopoietic potential is preserved in
the elderly under basal condition (steady state) and it is only
the capacity of stem cell renewal after hematological stress
that declines gradually with advancing age. Thus, in the
absence of stressing conditions, the absolute numbers of
eosinophils and basophils in young versus older adults remain
quite similar. Age-associated architectural changes also
occur in secondary lymphoid tissues. The characteristics of
lymphocytes in the spleen and lymph nodes change signifi-
cantly with age. Peripheral B cell numbers do not decline
with age, but a lower antibody response and a decreased
ability to produce high affinity antibodies are observed. This
suggests impaired humoral (B cell) responses in older
persons. In addition, attenuation of dendritic cell function is
observed with increasing age. As it will be discussed, the link
between age-associatedmodifications in the immune system
and the skin test positivity is yet to be demonstrated.
Asthma is not a rare entity in the elderly population. In
studies performed in the UK, asthma prevalence in the
elderly ranged from 2.5% to 6.5%.8e10 A survey study pub-
lished in 2005 found that asthma in elderly Hispanic and
non-Hispanic white population of Texas, USA11 had a prev-
alence of 6.3% (current asthma) and 9.0% (probable
asthma). The contribution of atopy in the occurrence of
asthma in the elderly has not been properly established.
The current review aims at evaluating whether atopy, asassessed by specific serum IgE, or skin reactivity to aero-
allergens, is influenced by the aging process.
Methods
To record our current knowledge on the impact of age on
atopy, a systematic literature search using MEDLINE for the
years 1966e2010 was performed. The algorithm of the
methodology that was applied included the term “aged”, as
MeSH (Medical Subject Headings) term together with
“atopy”, “allergy”, “allergen” and “IgE”; since “aged”
identifies subjects aged between 65 and 79, the string “aged,
80 and over” was added. Studies performed only in young
adult and children populations were excluded. The search
was restricted to human studies and articles published in
English language. All articles that were identified were
examined for eligibility by some of the authors (NS, AC, GA
and MM), and disagreements were discussed with the
remaining authors; articles were accepted for further eval-
uation by consensus. In addition to extracting information on
the design of each study, we recorded the method applied to
assess theatopic status (serumspecific IgE,prick test) andthe
characteristics of the studied population (healthy people,
asthmatics and/or rhinitics). We excluded articles that used
total IgE levels as a descriptor of atopy, because this endpoint
is known to be influenced by various factors, such as smoking
habit, gender, environmental exposure, parasitic infections,
which could confound the outcomes of the current review.
The majority of studies were of cross-sectional design.
Moreover, the evaluation of the atopic status inmany studies
was performed without discriminating between specific IgE
levels and the response to allergen skin prick test (SPT), or
between healthy and atopic subjects or subjects with
chronic respiratory diseases. Thismust be taken into account
when comparing different studies. We did not apply any age
limit, but we ensured that extreme ages were incorporated.
Because of the restrictive criteria used in the current
review, only 16 studies were included in the analysis. Table 1
summarizes themain characteristics (sample size, age range,
atopy, sample features, and the effect of age on atopy).
Table 1 List of the studies included in the current review. The main characteristics for each study are depicted. sIgE: serum
specific IgE.
Author (date) Sample
size
Age Atopy Outcomes Sample features Effect of age on
atopy outcome
Gergen et al. 1987 16204 12e74 Prick test Healthy Decreased with age
Wuthrich et al. (1996) 8344 18e60 sIgE
Prick test
Healthy Decreased with age
Kerkhof et al. (2003) 2327 20e70 sIgE
Prick test
Healthy Decreased with age
Sapingi et al. (1998) 1905 8e73 Prick test Healthy Decreased with age
Nakazawa et al. (1994) 1049 18e99 sIgE Healthy Decreased with age
Barbee et al. (1981) 311 9e65 sIgE
Prick test
Healthy Decreased with age
Barbee et al. (1981) 2743 6e90 sIgE Healthy Decreased with age
Freidhoff et al. (1984) 320 20e60 Prick test Healthy Decreased with age
Hanneuse et al. (1978) 326 16e69 sIgE Atopics Decreased with age
Karakaya et al. (2006) 222 17e68 Prick test Asthmatics
and/or rhinitics
Decreased with age
Niemeijer et al. (1992) 499 4e75 Prick test Asthmatics Decreased with age
Eriksson et al. (1996) 7099 14-70 Prick test Asthmatics
and/or rhinitics
Decreased with age
Mitsunobu et al. (2000) 263 31e90 sIgE Asthmatics Decreased with age
Hsu et al. (2004) 504 <15e64þ sIgE Asthmatics Decreased with age
Stoy et al. (1981) 331 n.d sIgE
Prick test
Asthmatics
and Healthy
Decreased with age
Huss et al. (2001) 80 >65 Prick test Asthmatics Increased with age
Crawford et al. (2004) 132 25e75 Prick test Asthmatics
and/or rhinitics
Increased with age
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Atopy decreases with aging
Several studies have found decreasing prevalence of atopy
with age either in general population samples or in pop-
ulation samples of healthy, i.e. with no allergy-related
symptoms, humans. The National Health And Nutrition
Examination Survey (NHANES) II is the largest prick punc-
ture skin study reported, including a total of 16204 partic-
ipants from the non institutionalized US population, who
were skin prick tested to eight allergens. Some 30% of
individuals aged 12e24 years had at least one positive skin
test; the prevalence of positive response dropped to 8% in
the group of subjects aged 65e74.12 In another analysis
performed in a total of 8179 subjects from the NHANES
population, aged between 30 and 75 years, the authors
demonstrated a reduction in the prevalence of positive skin
responses with increasing age.13 An important contribution
to the relationship between age and atopy derives from the
results of the SAPALDIA study.14 In this large, cross-
sectional study of healthy subjects (18e60 yrs), atopy was
evaluated in relation to age, gender and smoke habit. The
study documented a reduced prevalence of atopy in the
most advanced ages: the prevalence of allergen-specific IgE
antibody concentrations, positive prick tests and allergic
manifestations decreased significantly by 23%, 21% and 21%
respectively, with every 10-year increment in age. The
lower prevalence of atopy in older subjects was alsodocumented in a Dutch general population study,15 which
was performed with the aim of identifying cut-off values of
total IgE to discriminate between subjects with and without
sensitizations to common aeroallergens. In order to create
receiver operator characteristic curves, at least one posi-
tive SPT or specific IgE levels against at least one allergen
served as “gold standard” for sensitization. The study
sample included subjects aged 20e70 years, and was
stratified in two age groups (20e44 and 45e70 years). The
authors found a significantly higher number of subjects with
at least one positive SPT or specific IgE levels against at
least one allergen in the 20e44 year group as opposed to
the 45e70 year group, both in subjects with allergy symp-
toms and those with no symptoms. Similar findings were
documented in a stratified population sample of 8e73 year-
old individuals.16 In another study carried out in a general
healthy population (age range: 18e99 yrs), specific IgE
antibodies to mites and Japanese cedar pollen were found
to be lower in the most advanced ages. In particular, the
percentage of subjects who were positive for anti-mite
antibodies decreased from 27% in the young group to 15%
in the older group, and even more in the over 70 year
group.17 By testing the sensitivity to the most common
aeroallergens in a community population sample, Barbee
and colleagues18,19 found the highest prevalence of positive
SPT in subjects ranging 6e14 yrs and 20e34 yrs, and the
lowest prevalence in women older than 75 yrs. Also,
Freidhoff and colleagues20 demonstrated a tendency of SPT
positivity to decrease between 20 and 60 yrs of age in
a random sample of 320 adults.
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between atopy and age was assessed in individuals affected
by allergic respiratory diseases. This was first reported in
1978 by Hanneuse and colleagues,21 in 326 allergic patients,
in whom specific IgE levels to the most common aero-
allergens were found to be significantly lower in the older
subjects. In a prospective study,22 specifically designed to
determine possible changes in atopy over a follow-up
period of a short period, 2 years, 222 asthmatics and rhi-
nitics (age range: 17e68 yrs) were skin tested for common
aeroallergens: repeat tests showed that the prevalence of
positive SPT dropped from 58.6% to 47.7%, with the most
important factor affecting this trend being time itself. In
another investigation, the prevalence of skin test reactivity
to at least one allergen was inversely correlated with age in
an asthmatic population aging 4e75 yrs.23 This was true for
all the common aeroallergens tested, except for grass
pollen. In yet another large study on asthmatics and/or
rhinitics,24 the prevalence of skin reactivity to allergens,
equal to 44% for the entire study group, was found to
decrease with age: the prevalence of positive SPT was 61%
in the youngest group (14e20 yrs), and only 18% in the oldest
(61e70 yrs). Another study performed in Japan supports this
claim25; the population tested consisted of 263 asthmatics
with average age of 60 (range 31e90). The specific IgE levels
were significantly lower in the oldest subjects. Asthma and
age were the main variables explored in a study performed
in Taiwan26; 504 asthmatics were divided according to age
of onset. Specific IgE levels were found to be lower in the
oldest individuals, demonstrating that atopy is more prev-
alent in early onset than in late-onset asthma. Finally, the
changes in specific IgE and SPT responses with age were
evaluated in a total of 331 individuals consisting of asth-
matics and healthy subjects.27 Results demonstrated
a tendency of specific IgE levels and SPT positivity to be
lower in the most advanced ages in both groups.
Atopy does not decrease with aging
Among the studies that met the criteria for inclusion in the
current review, only two showed a lack of decline in the
prevalence of atopy with aging. However both studies have
limitations. The prevalence of allergy in asthma in the
elderly was determined in a study performed in Baltimore,
USA28: in 80 asthmatics older than 65 years, 75% presented
with at least one sensitization to common airborne aller-
gens as assessed by SPT. The second study was a cross-
sectional survey performed in adult asthmatics and rhinitics
to assess the age effects on atopy.29 The sample consisted
of 132 individuals with mean age of 55 years, stratified
according to age in six groups (25e34, 35e44, 45e54,
55e64, 65e74). The prevalence of positive SPT was similar
among the age groups in the subgroup of asthmatics (71
subjects). The small number of subjects in this study
precludes any meaningful conclusion.
Discussion
The findings of our review are consistent with the notion
that the prevalence of allergic sensitization is lower in themost advanced ages. Unfortunately, no large, longitudinal
studies among the general population have been conducted
to confirm that atopy decreases with increasing ages. This
is a major deficiency, because a significant caveat of cross-
sectional studies in this field is that a lower prevalence of
atopy in older groups may simply reflect a lower prevalence
of atopy in the same individuals when they were young and
not a reduction in atopic status with age. This should be
seriously considered given the fact that atopy primarily
develops in childhood and that the overall prevalence of
atopy has been steadily increasing.30 Law and colleagues
published an interesting observation that supports the
above possibility.31 They measured specific IgE in stored
serum samples of all men attending a general medical clinic
in 1996-98 and compared the results to age- and month of
attendance-matched samples of men that were seen in the
same clinic in 1981-82 and in 1975e76. Their results indi-
cated a steady increase in the percentage of Phadiatop
positive samples between the 3 cross-sectional evaluations.
However, when they compared the results from those 3
testing periods for men born in 1932e42, no difference in
the prevalence of atopy was detected. These results
suggest that the prevalence of atopy may not decline with
increasing age and that more recent cohorts are more likely
to have atopy.Limitations of the current review
The literature review that we conducted has limitations.
First, atopy is not evaluated in a consistent manner across
studies in that increased total IgE levels or positive SPT
responses to allergens are used interchangeably. The level
of total IgE is influenced by independent factors such as
gender, smoke habit, parasitic infections, environmental
exposure to allergens and number of sensitizations. As
a result, we do not believe that total IgE concentration is
the most appropriate clinical test to determine atopy.
Hence, we selected only those studies in which atopy was
defined by means of specific IgE concentrations toward
aeroallergens and/or SPT positivity to at least one aero-
allergen. This drastically limited the number of available
publications for review. Second, several studies examining
the effect of age on atopy suffer from small samples and/or
narrow age range; these two parameters are pivotal in
allowing reliable conclusions to be drawn. For example, the
majority of studies which conclude that atopy does not
change with age had to be disregarded in this review
because of relatively small number of study subjects, as
judged by the authors. Finally, the current review does not
judge the fact that the oldest studies may have used not-
standardized allergen extracts, which could have influ-
enced the measurements of the indicators of atopy. This is
a common issue that should be kept in mind when inter-
preting the results. On the basis of different designs and
methods for estimation of sensitization, and the possible
influence of the change in the last decades in the frequency
of sensitization in children, adolescents and young adults,
no firm conclusion can be drawn on whether there is
a decreased sensitization rate in elderly healthy and
allergic populations.
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the elderly
With the ambiguity of the question whether atopy
decreases in older age aside, our review indicates that the
point prevalence of allergic respiratory disease remains
high in older adults. In Law’s study, Phadiatop positivity
was approximately 35% in men 54e64 years of age.31 Among
a population of 1888 individuals over 65 years of age, Ariano
and colleagues32 recognized 21 subjects with asthma, who
had high prevalence (72%) of skin reactivity for dermato-
phagoides, parietaria, grasses, and olive in individuals with
late-onset asthma. Also, in a retrospective analysis of 1002
allergic asthmatics and/or rhinitics aged 8e77 years from
our Outpatient Allergy Clinic (unpublished observations),
the number of sensitizations did not change with age;
indeed, the average number was 2.74  1.5 (mean  SD) in
the 274 subjects with age <24 years (25 percentile),
2.71  1.6 in the 488 subjects with age between 25 and
44 years (25e75 percentile), and 2.53  1.5 in the 240
subjects aged between 44 and 77 years (75 percentile)
(ANOVA: p Z 0.25).
The natural course of allergy is based on persistent
antigen exposure; the repeated stimulation with identical
antigenic proteins induces on one hand the expression of
new surface molecules and, on the other hand, the
expansion of effector and memory cells. It follows that,
with aging, the number of naive cells decreases and the
sensitized cells increase. In allergic asthma there is
a continuous stimulation of T lymphocytes by several aer-
oallergens, which can lead to a decrease in naive T cells.
Additional factors that have not been considered in the
context of the effect of age on allergy are all the inflam-
matory events downstream from IgE. These include mast
cell and basophil mediator releasability, which determines
the quantity of inflammatory mediators released for a given
magnitude of IgE receptor bridging, the responsiveness of
other inflammatory cells to the chemoattractive and
activating signals of mast cell and basophil mediators, as
well as the responsiveness of target organs (e.g. vascula-
ture, airway smooth muscle, glandular apparatus) to the
effects of mediators derived from allergy-activated cells.
Furthermore, the ability of the immune system to down-
regulate an ongoing inflammatory response needs to be
taken into account.
The clinical importance of allergy in the elderly
Given that the above-described functions have not been
studied in older adults in comparison to younger pop-
ulations, it would be very hard to argue that an age-related
reduction in the production of IgE, if real, diminishes the
clinical importance of allergy in the elderly. In other words,
despite a decreased prevalence of atopy, the severity of
allergic conditions may be increased in older age. It has
been suggested, for example, that the highest risk for
asthma hospitalization derives from a combination of atopy
and viral infections.33,34 Although, again, the role of viral
infections in conjunction with atopic status has not been
studied in the elderly, alterations of immune responses
could increase susceptibility to infection, which, in turn,could amplify the inflammatory response and the synergism
between atopic status and viral infections in asthma in this
population. Atopy appears to be more frequent in elderly
patients with early onset than in those with late-onset
asthma. Parameswaran and colleagues35 found that history
of atopy was the strongest predictor of asthma in the
elderly population. Another aspect of the assessment of
atopy in the elderly is related to its possible role in the
differential diagnosis between asthma and COPD in the
geriatric patient. Indeed, if, on one hand, asthma main-
tains its basic clinical characteristics in the elderly, but on
the other hand, features of COPD develop as the patient
ages, the differences in terms of clinical and functional
manifestations between these two conditions become
less evident. The attenuation of reversibility of bronchial
obstruction in older adults both by physiologic mechanisms
(lung inflation),36 and by bronchodilators,37 the history of
smoke exposure and the low perception of symptoms
complicate the clinical phenotype of the elderly asthmatic
subject. In this context, some authors have proposed the
evaluation of atopy as a useful tool in the differential
diagnosis between asthma and COPD in the elderly.38
However, this matter has not been investigated thor-
oughly and current guidelines39 do not include the assess-
ment of the allergic component to distinguish asthma
from COPD. The major problem is that atopic individuals
may develop COPD because of environmental exposures or
because of intrinsic susceptibility without asthma being
part of their pathology. On the other hand, it is now well
recognized that the lower airways of almost all atopic
individuals are inflamed and/or show evidence of sub-
clinical physiologic abnormalities.40
Allergic reactions in older adults, when taking place, can
have the same or even worse manifestations, compared to
younger people, given the fact that various systems and
organs, the function of which is also in decline, may not be
able to compensate. Theoretically, for the same degree of
a systemic anaphylactic reaction, the compensation that
the cardiovascular system can mount in a young allergic
individual is expected to be much more effective than that
in an older person. In addition, as mentioned previously,
known interactions between allergy and other conditions
(primarily viral, but also bacterial infections, pollutant-
induced oxidative stress, etc.) may be potentiated in the
elderly in a manner that results in more severe manifes-
tations of allergic respiratory disease. Finally, the severity
of allergy-related attacks in the elderly may be influenced
by the low perception of symptoms41 and by the common
presence of comorbidities42,43 that may interact with and
increase the side-effects or decrease the effectiveness of
conventional allergy and asthma treatment. Therefore,
allergy diagnosis and management should be considered in
all upper and lower respiratory diseases in the elderly.
Regardless of age, assessment of atopy is essential in
a comprehensive evaluation of the respiratory patient
offering the possibility of environmental control (removal
of allergens) and appropriate therapy (e.g., anti-IgE or
allergen immunotherapy). This is particularly important
based on the prevalence of asthma in the elderly pop-
ulations.11 Atopy may be an independent predictor of
airway hyperresponsiveness in the elderly, based on our
review of the existing literature.44 This is of great
656 N. Scichilone et al.importance, given that in the respiratory geriatric patient,
airway hyperresponsiveness is associated with a more rapid
decline in pulmonary function and a greater risk of clinical
exacerbations.45
Possible explanations for “false negative” skin test
responses in the elderly
Criteria for interpreting skin test results differ between
younger and older patients, and the incorrect interpretation
of skin testing may lead to false negative responses. One
possible explanation can be found in the age-associated
reduction in skin reactivity of the elderly to histamine and
allergens. Skassa-Brociek et al.46 demonstrated a decrease
in skin tests reactivity to histamine after 50 years of age,
reaching a plateau after the age of 60. Moreover even if
a wheal to histamine was reported in all subjects aged over
70 years, the flare was difficult to detect in a proportion of
subjects. Thus, in geriatric age the intensity of the skin
response should be expressed as the ratio between allergen
and histamine induced wheals. In addition, the skin reac-
tivity varies in the different body regions; in fact, as
different studies have demonstrated,47 the back is more
reactive than the forearm, and this difference is greater for
allergen than for histamine skin tests. Prior to performing
a skin prick test in the elderly, the area of the skin should be
examined for atrophic or photo changes, which may influ-
ence the response to allergens.48 Indeed, the skin of older
people undergoes atrophy that results in fewer cell layers
and decreased cellularity and collagen. The marked reduc-
tion in blood vessels and mast cells offers less potential
binding sites for allergen and less histamine to produce
wheal and flare.49,50 In the photo-damage of the skin, which
is strictly related to the prolonged exposure to sun, the
reason of a false negative response in skin prick test can be
found in the role on mast cells, which are altered by solar
damage.51,52 Other factors could affect negatively the
response to skin test in the elderly such as medications,
especially antihistamines and antidepressants. Finally, the
possibility exists that older subjects are no longer exposed to
specific allergens they were positive to, and this may greatly
reduce the skin test responses. A negative skin prick test
cannot completely exclude the presence of an allergic
condition. The concept of localized mucosal allergy in the
absence of atopy has recently been proposed, with the
existence of local allergic rhinitis with nasal production of
specific IgE antibodies in the absence of atopy in over 40% of
rhinitic subjects classified as non-allergic. This may further
complicate the relationship between the presence of atopy
in the geriatric age.53,54
The role of allergy in the management of asthma in
the elderly
Identification of an allergic component of asthma in the
elderly patient may influence treatment. First, the recog-
nition of allergens as possibly responsible for the respira-
tory condition allows for preventive environmental
strategies to be applied. Older individuals spend more time
in the same indoor environment,11 compared to younger
adults and it is conceivable that the impact ofenvironmental control, particularly for indoor allergens
(mites, molds, pets, cockroach) will be higher in this age
group. However, no published study has addressed this
hypothesis. Second, with the advent of better or easier to
use methods of immunomodulation for allergy treatment
(e.g. subcutaneous immunotherapy using effective adju-
vants to increase the immune response while reducing the
risk of systemic reactions, sublingual immunotherapy, anti-
IgE treatment) elderly patients may be managed more
effectively. Immunotheraphy should be considered in
elderly individuals with specific indications.55 Indeed, age
per se does not preclude the use of allergen desensitiza-
tion, as demonstrated by Asero,56 who confirmed the effi-
cacy of injection immunotherapy in elderly individuals.
However, because of the frequent occurrence of comorbid
conditions and the use of concomitant medications that
could interfere with the immunotherapy, risks and benefits
should be carefully evaluated in the elderly. For example,
patients receiving beta-adrenergic blocking drugs are at
increased risk when receiving allergen immunotherapy
because treatment of anaphylaxis can be more difficult. In
these cases, immunotherapy should not be initiated unless
benefits and risks are considered and discussed with the
patient.Conclusions
The immune system undergoes an involution process with
consequent decline in immunoglobulin production, including
IgE. This has led to consider asthma in the elderly a disease
of non-allergic pathogenesis. As a consequence, atopy has
been relegated to a minor role in the clinical assessment of
the geriatric patient. This concept has probably contributed
to underdiagnosis of asthma in the elderly. This can have
clinical consequences because management may suffer; it
may also have a substantial impact on public health direct
and indirect costs.57 Today, asthma in the elderly is a well-
recognized condition, with unique features reflecting the
co-existence of other diseases, the use of multiple respira-
tory and non-respiratory drugs, individual responsiveness
to treatment, and different perception of symptoms.58
Although available data seem to favor the decline of
allergen sensitization with age, the prevalence of allergic
sensitizations in the elderly population with respiratory
symptoms is substantial enough to warrant evaluation of the
atopic condition. This approach will improve diagnosis and
could allow the introduction of allergy-specific management
leading to significant reduction in asthma morbidity.
Conflict of interest
None.References
1. Compston JE. Bone marrow and bone: a functional unit. The
Journal of Endocrinology 2002;173(3):387e94.
2. Gomez CR, Boehmer ED, Kovacs EJ. The aging innate
immune system. Current Opinion in Immunology 2005;17(5):
457e62.
Atopy in the elderly 6573. Sansoni P, Vescovini R, Fagnoni F, Biasini C, Zanni F, Zanlari L,
et al. The immune system in extreme longevity. Experimental
Gerontology 2008;43(2):61e5.
4. Weksler ME, Szabo P. The effect of age on the B-cell reper-
toire. Journal of Clinical Immunology 2000;20(4):240e9.
5. Eaton SM, Burns EM, Kusser K, Randall TD, Haynes L. Age-
related defects in CD4 T cell cognate helper function lead to
reductions in humoral responses. The Journal of Experimental
Medicine 2004;200(12):1613e22.
6. Haynes L, Eaton SM. The effect of age on the cognate function
of CD4þT cells. Immunological Reviews 2005;205:220e8.
7. Agrawal A, Agrawal S, Gupta S. Dendritic cells in human aging.
Experimental Gerontology 2007;42(5):421e6.
8. Dickinson JA, Meaker M, Searle M, Ratcliffe G. Screening older
patients for obstructive airways disease in a semi-rural prac-
tice. Thorax 1999;54(6):501e5.
9. Parameswaran K, Hildreth AJ, Chadha D, Keaney NP, Taylor IK,
Bansal SK. Asthma in the elderly: underperceived, under-
diagnosed and undertreated; a community survey. Respiratory
Medicine 1998;92(3):573e7.
10. Soriano JB, Kiri VA, Maier WC, Strachan D. Increasing preva-
lence of asthma in UK primary care during the 1990s. Inter-
national Journal of Tuberculosis and Lung Disease 2003;7(5):
415e21.
11. Arif AA, Rohrer JE, Delclos GL. A population-based study of
asthma, quality of life, and occupation among elderly Hispanic
and non-Hispanic whites: a cross-sectional investigation. BMC
Public Health 2005;5:97.
12. Gergen P, Turkeltaub P, Kovar M. The prevalence of allergic
skin test reactivity to eight common aeroallergens in the U.S.
population: results from the second national health and
nutrition examination survey. Journal of Allergy and Clinical
Immunology 1987;80(5):669e79.
13. Gergen PJ, Turkeltaub PC, Sempos CT. Is allergen skin test
reactivity a predictor of mortality? Findings from a national
cohort. Clinical & Experimental Allergy 2000;30(12):1717e23.
14. Wuthrich B, Schindler C, Medici TC, Zellweger JP,
Leuenberger P. IgE levels, atopy markers and hay fever in
relation to age, sex and smoking status in a normal adult Swiss
population. SAPALDIA (Swiss Study on Air Pollution and Lung
Diseases in Adults) Team. International Archives of Allergy and
Immunology 1996;111(4):396e402.
15. Kerkhof M, Dubois AE, Postma DS, Schouten JP, de Monchy JG.
Role and interpretation of total serum IgE measurements in the
diagnosis of allergic airway disease in adults. Allergy 2003;58
(9):905e11.
16. Sapigni T, Biavati P, Simoni M, Viegi G, Baldacci S, Carrozzi L,
et al. The Po river delta respiratory epidemiological Survey: an
analysis of factors related to level of total serum IgE. European
Spine Journal 1998;11(2):278e83.
17. Nakazawa T, Houjyo S, Dobashi K, Sato K. Influence of aging
and sex on specific IgE antibody production. Internal Medicine
1994;33(7):396e401.
18. Barbee RA, Brown WG, Kaltenborn W, Halonen M. Allergen
skin-test reactivity in a community population sample: corre-
lation with age, histamine skin reactions and total serum
immunoglobulin E. The Journal of Allergy and Clinical Immu-
nology 1981;68(1):15e9.
19. Barbee RA, Halonen M, Lebowitz M, Burrows B. Distribution of
IgE in a community population sample: correlations with age,
sex, and allergen skin test reactivity. The Journal of Allergy
and Clinical Immunology 1981;68(2):106e11.
20. Freidhoff LR, Meyers DA, Marsh DG. A genetic-epidemiologic
study of human immune responsiveness to allergens in an
industrial population. II. The associations among skin sensi-
tivity, total serum IgE, age, sex, and the reporting of allergies
in a stratified random sample. The Journal of Allergy and
Clinical Immunology 1984;73(4):490e9.21. Hanneuse Y, Delespesse G, Hudson D, de Halleux F,
Jacques JM. Influence of ageing on IgE-mediated reactions in
allergic patients. Clinical Allergy 1978;8(2):165e74.
22. Karakaya G, Kalyoncu AF. The natural course of atopy deter-
mined by skin prick tests in patients with bronchial asthma
and/or rhinitis. Allergologia et immunopathologia 2006;34(6):
257e62.
23. Niemeijer NR, de Monchy JG. Age-dependency of sensitization
to aero-allergens in asthmatics. Allergy 1992;47:431e5.
24. Eriksson NE, Holmen A. Skin prick tests with standardized
extracts of inhalant allergens in 7099 adult patients with
asthma or rhinitis: cross-sensitizations and relationships to age,
sex, month of birth and year of testing. Journal of Investiga-
tional Allergology and Clinical Immunology 1996;6:36e46.
25. Mitsunobu F, Mifune T, Hosaki Y, Ashida K, Tsugeno H,
Okamoto M, et al. IgE-mediated and age-related bronchial
hyperresponsiveness in patients with asthma. relationship to
family history of the disease. Age and Ageing 2000;29(3):
215e20.
26. Hsu JY, King SL, Kuo BI, Chiang CD. Age of onset and the
characteristics of asthma. Respirology 2004;9(3):369e72.
27. Stoy PJ, Roitman-Johnson B, Walsh G, Gleich GJ, Mendell N,
Yunis E, et al. Aging and serum immunoglobulin E levels,
immediate skin tests, RAST. The Journal of Allergy and Clinical
Immunology 1981;68(6):421e6.
28. Huss K, Naumann PL, Mason PJ, Nanda JP, Huss RW, Smith CM,
et al. Asthma severity, atopic status, allergen exposure and
quality of life in elderly persons. Annals of Allergy, Asthma, &
Immunology 2001;86(5):524e30.
29. Crawford WW, Gowda VC, Klaustermeyer WB. Age effects on
objective measures of atopy in adult asthma and rhinitis.
Allergy and Asthma Proceedings 2004;25(3):175e9.
30. Linneberg A, Gislum M, Johansen N, Husemoen LL,
Jorgensen T. Temporal trends of aeroallergen sensitization
over twenty-five years. Clinical & Experimental Allergy 2007;
37(8):1137e42.
31. Law M, Morris JK, Wald N, Luczynska C, Burney P. Changes in
atopy over a quarter of a century, based on cross sectional
data at three time periods. British Medical Journal 2005;330
(7501):1187e8.
32. Ariano R, Panzani RC, Augeri G. Late onset asthma clinical and
immunological data: importance of allergy. Journal of Inves-
tigational Allergology and Clinical Immunology 1998;8(1):
35e41.
33. Heymann PW, Carper HT, Murphy DD, Platts-Mills TA, Patrie J,
McLaughlin AP, et al. Viral infections in relation to age, atopy,
and season of admission among children hospitalized for
wheezing. The Journal of Allergy and Clinical Immunology
2004;114(2):239e47.
34. Peebles Jr RS. Viral infections, atopy, and asthma: is there
a causal relationship? The Journal of Allergy and Clinical
Immunology 2004;113(1 Suppl):S15e8.
35. Parameswaran K, Hildreth AJ, Taylor IK, Keaney NP, Bansal SK.
Predictors of asthma severity in the elderly: results of
a community survey in Northeast England. Journal of Asthma
1999;36:613e8.
36. Scichilone N, Marchese R, Catalano F, Togias A, Vignola AM,
Bellia V. The bronchodilatory effect of deep inspiration
diminishes with aging. Respiratory Medicine 2004;98:838e43.
37. Kizkin O, Turker G, Hacievliyagil SS, Gunen H. Asthma, age,
and early reversibility testing. Journal of Asthma 2003;40:
317e21.
38. Sin BA, Akkoca O, Saryal S, Oner F, Misirligil Z. Differences
between asthma and COPD in the elderly. Journal of Inves-
tigational Allergology and Clinical Immunology 2006;16:
44e50.
39. Bousquet J, Clark TJ, Hurd S, et al. GINA guidelines on asthma
and beyond. Allergy 2007;62:102e12.
658 N. Scichilone et al.40. Togias A. Rhinitis and asthma: evidence for respiratory system
integration. Journal of Allergy and Clinical Immunology 2003;
111:1171e83.
41. Connolly MJ, Crowley JJ, Charan NB, Nielson CP, Vestal RE.
Reduced subjective awareness of bronchoconstriction
provoked by methacholine in elderly asthmatic and normal
subjects as measured on a simple awareness scale. Thorax
1992;47(6):410e3.
42. van Manen JG, Bindels PJ, Dekker EW, Ijzermans CJ,
Bottema BJ, van der Zee JS, et al. Added value of co-morbidity
in predicting health-related quality of life in COPD patients.
Respiratory Medicine 2001;95(6):496e504.
43. Scichilone N, Paglino G, Battaglia S, Martino L, Interrante A,
Bellia V. The mini nutritional assessment is associated with the
perception of dyspnoea in older subjects with advanced COPD.
Age and Ageing 2008;37(2):214e7.
44. Scichilone N, Messina M, Battaglia S, Catalano F, Bellia V. Airway
hyperresponsiveness in the elderly: prevalence and clinical
implications. European Respiratory Journal 2005;25:364e75.
45. Hospers JJ, Postma DS, Rijcken B, Weiss ST, Schouten JP.
Histamine airway hyper-responsiveness and mortality from
chronic obstructive pulmonary disease: a cohort study. Lancet
2000;356:1313e7.
46. Skassa-Brociek W, Manderscheid JC, Michel FB, Bousquet J.
Skin test reactivity to histamine from infancy to old age.
Journal of Allergy and Clinical Immunology 1987;80:711e6.
47. Nelson HS, Knoetzer J, Bucher B. Effect of distance between
sites and region of the body on results of skin prick tests.
Journal of Allergy and Clinical Immunology 1996;97:596e601.
48. King MJ, Lockey RF. Allergen prick-puncture skin testing in the
elderly. Drugs Aging 2003;20:1011e7.49. Glogau RG. Physiologic and structural changes associated with
aging skin. Journal of Clinical Dermatology 1997;15:555e9.
50. Ortonne JP. Dyspigmentation of aged skin. European Journal of
Dermatology 2001;11:168e9.
51. Gilchrest BA, Stoff JS, Soter NA. Chronologic aging alters the
response to ultraviolet-induced inflammation in human skin.
Journal of Investigative Dermatology 1982;79:11e5.
52. Vocks E, Sta¨nder K, Rakoski J, Ring J. Suppression of imme-
diate-type hypersensitivity elicitation in the skin prick test by
ultraviolet B irradiation. Photodermatol Photoimmunol Pho-
tomed 1999;15:236e40.
53. Rondo´n C, Don˜a I, Lo´pez S, Campo P, Romero JJ, Torres MJ,
et al. Seasonal idiopathic rhinitis with local inflammatory
response and specific IgE in absence of systemic response.
Allergy 2008;63:1352e8.
54. Rondo´n C, Canto G, Blanca M. Local allergic rhinitis: a new
entity, characterization and further studies. Current Opinion
in Allergy and Clinical Immunology 2010;10:1e7.
55. Cox L, Cohn JR. Duration of allergen immunotherapy in respi-
ratory allergy: when is enough, enough? Annals of Allergy,
Asthma, & Immunology 2007;98(5):416e26.
56. Asero R. Efficacy of injection immunotherapy with ragweed
and birch pollen in elderly patients. International Archives of
Allergy and Immunology 2004;135(4):332e5.
57. Baptist AP, Deol BB, Reddy RC, Nelson B, Clark NM. Age-specific
factors influencing asthma management by older adults.
Qualitative Health Research 2010;20:117e24.
58. Chotirmall SH, Watts M, Branagan P, Donegan CF, Moore A,
McElvaney NG. Diagnosis and management of asthma in older
adults. Journal of the American Geriatrics Society 2009;57:
901e9.
